PDS Biotechnology Corporation (PDSB)
PDSB Stock Price Chart
Explore PDS Biotechnology Corporation interactive price chart. Choose custom timeframes to analyze PDSB price movements and trends.
PDSB Company Profile
Discover essential business fundamentals and corporate details for PDS Biotechnology Corporation (PDSB) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
30 Sept 2015
Employees
24.00
Website
https://www.pdsbiotech.comCEO
Frank K. Bedu-Addo
Description
PDS Biotechnology Corporation is a clinical-stage biopharmaceutical firm dedicated to advancing innovative, multi-functional immunotherapies to combat cancer. Its primary drug candidate, PDS0101 (HPV16), is currently undergoing Phase II clinical trials, positioned as an initial treatment option for recurrent or metastatic head and neck cancer, human papillomavirus (HPV)-associated malignancies, and cervical cancer. The company's developmental pipeline further includes several preclinical product candidates. These comprise PDS0102, utilizing T-cell receptor gamma alternate reading frame protein (TARP) for prostate and breast cancers; PDS0103 (MUC-1) targeting ovarian, colorectal, lung, and breast cancers; and PDS0104, which incorporates Tyrosinase-related protein 2 for the treatment of melanoma. Beyond oncology, PDS Biotechnology is also engaged in developing treatments for infectious diseases, with candidates such as PDS0201 for tuberculosis, PDS0202 as an investigational influenza vaccine, and PDS0203, a vaccine aimed at preventing COVID-19. The company has established strategic partnerships and licensing agreements with notable entities including the National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is headquartered in Florham Park, New Jersey.
PDSB Financial Timeline
Browse a chronological timeline of PDS Biotechnology Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 Aug 2026
EPS estimate is -$0.13.
Earnings released on 13 May 2026
EPS came in at -$0.13 surpassing the estimated -$0.15 by +13.33%.
Earnings released on 30 Mar 2026
EPS came in at -$0.14 surpassing the estimated -$0.20 by +30.00%.
Earnings released on 13 Nov 2025
EPS came in at -$0.19 surpassing the estimated -$0.21 by +9.52%.
Earnings released on 13 Aug 2025
EPS came in at -$0.21 surpassing the estimated -$0.24 by +12.50%.
Earnings released on 14 May 2025
EPS came in at -$0.21 surpassing the estimated -$0.25 by +16.00%.
Earnings released on 27 Mar 2025
EPS came in at -$0.21 surpassing the estimated -$0.29 by +27.59%.
Earnings released on 14 Nov 2024
EPS came in at -$0.29 matching the estimated -$0.29.
Earnings released on 13 Aug 2024
EPS came in at -$0.23 surpassing the estimated -$0.31 by +25.81%.
Earnings released on 15 May 2024
EPS came in at -$0.30 surpassing the estimated -$0.37 by +18.92%.
Earnings released on 27 Mar 2024
EPS came in at -$0.34 surpassing the estimated -$0.39 by +12.82%.
Earnings released on 14 Nov 2023
EPS came in at -$0.35 surpassing the estimated -$0.42 by +16.67%.
Earnings released on 14 Aug 2023
EPS came in at -$0.37 matching the estimated -$0.37.
Earnings released on 15 May 2023
EPS came in at -$0.32 falling short of the estimated -$0.31 by -3.23%.
Earnings released on 28 Mar 2023
EPS came in at -$0.67 falling short of the estimated -$0.30 by -123.33%.
Earnings released on 14 Nov 2022
EPS came in at -$0.26 matching the estimated -$0.26.
Earnings released on 8 Aug 2022
EPS came in at -$0.20 surpassing the estimated -$0.30 by +33.33%.
Earnings released on 11 May 2022
EPS came in at -$0.32 .
Earnings released on 31 Mar 2022
EPS came in at -$0.23 surpassing the estimated -$0.24 by +4.17%.
Earnings released on 10 Nov 2021
EPS came in at -$0.24 falling short of the estimated -$0.22 by -9.09%.
Earnings released on 12 Aug 2021
EPS came in at -$0.22 falling short of the estimated -$0.21 by -4.76%.
PDSB Stock Performance
Access detailed PDSB performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
